EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2

MT Newswires Live

07/30

EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.

The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.

It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.

Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees "encouraging numbers" of patients being identified and scheduled for WiSE implants in the second half of the year.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2655841058"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2655841058\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2655841058?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655841058","market":"us","top_or_hot":-1,"title":"EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-30 11:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655841058","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655841058","pubTimestamp":1785382703,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market relea","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","EBR.AU":"EBR SYSTEMS INC-CDI"},"translate_title":"EBR Systems 在第二季度推出 46 台商业植入物，推进心脏起搏设备","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR.AU":1},"content_text":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}